Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1031 | 1024 | 1084 | 1320 | 1479 | - |
Fund Return | 3.08% | 2.36% | 8.36% | 9.71% | 8.14% | - |
Place in category | 894 | 830 | 71 | 624 | 374 | - |
% in Category | 65 | 58 | 5 | 60 | 42 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Dynamic Global Dividend | 5.21B | 24.57 | 1.89 | 10.07 | ||
Dynamic Global Dividend Series F | 5.21B | 25.96 | 3.02 | 11.34 | ||
Dynamic Global Dividend Series I | 5.21B | 27.22 | 4.05 | 12.48 | ||
Dynamic Global Dividend Series T | 5.21B | 24.62 | 1.93 | 10.09 | ||
Dynamic Power Global Growth USD | 2.41B | 31.15 | -8.79 | 9.50 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
TD U.S. Blue Chip Equity Fund I USD | 6.06B | 21.76 | 4.33 | 13.39 | ||
TD U.S. Blue Chip Equity Fund D USD | 6.06B | 22.99 | 5.34 | - | ||
RBC Priv US Lg Cap Cr Eq Pool Sr F | 5.85B | 34.66 | 13.63 | 14.27 | ||
DFA US Core Equity Class F | 5.73B | 29.97 | 12.02 | 13.14 | ||
AGF American Growth Class USD | 3.98B | 40.10 | 13.31 | 15.43 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 6.24 | 424.56 | +0.52% | |
Apple | US0378331005 | 4.68 | 242.70 | +0.20% | |
Visa A | US92826C8394 | 3.95 | 312.60 | +0.30% | |
JPMorgan | US46625H1005 | 3.58 | 243.13 | -0.02% | |
Thermo Fisher Scientific | US8835561023 | 3.53 | 544.93 | -0.13% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review